Dossier
Ervebo vaccine
Coverage of Ervebo vaccine in the Nexus archive.
- Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective in past outbreaks
Congo will receive 70,000 doses of the Ervebo vaccine for use against Ebola, which has been effective in past outbreaks. The allocation includes 20,000 doses for a Phase 3 clinical trial concerning the Bundibugyo virus and 50,000 doses for front-line and health workers. This step aims to boost efforts to contain an Ebola outbreak described as the fastest in history.
- Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective in past outbreaks
The World Health Organization and partners announced that Congo will receive 70,000 doses of the Ervebo vaccine. The allocation includes 20,000 doses for a Phase 3 clinical trial related to the Bundibugyo virus, with the remaining 50,000 doses intended for front-line workers and health personnel in eastern Congo.